LRRFIP1 anticorps (AA 200-250)
Aperçu rapide pour LRRFIP1 anticorps (AA 200-250) (ABIN960254)
Antigène
Voir toutes LRRFIP1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 200-250
-
Specificité
- Human LRRFIP1.
-
Purification
- Protein A purified
-
Immunogène
-
Amino acids 200-250 of human LRRFIP1.
Type of Immunogen: Synthetic peptide
-
-
-
-
Indications d'application
- Approved: WB (2 - 5 μg/mL)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.05 % BSA, 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store at 4°C for short term applications. For long term storage, aliquot and store at -20°C.
-
-
- LRRFIP1 (Leucine Rich Repeat (In FLII) Interacting Protein 1 (LRRFIP1))
-
Autre désignation
- TRIP / LRRFIP1
-
Sujet
-
Name/Gene ID: LRRFIP1
Synonyms: LRRFIP1, FLAP-1, FLAP1, FLIIAP1, GCF2, LRR FLII-interacting protein 1, HUFI-1, Tcf9, Tcf-9, TRIP, NEDD8-conjugating enzyme, TAR RNA-interacting protein, Transcription factor 9, GC-binding factor 2, GCF-2 -
ID gène
- 9208
-
UniProt
- Q32MZ4
Antigène
-